Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 89 results.
User Information
Export Records
  1. 1.   Exposure time versus cytotoxicity for anticancer agents
  2. Evans, David M; Fang,Jianwen; Silvers,Thomas; Delosh,Rene; Laudeman,Julie; Ogle,Chad; Reinhart,Russell; Selby, Michael; Bowles,Lori; Connelly,John; Harris,Erik; Krushkal, Julia; Rubinstein, Larry; Doroshow, James H; Teicher, Beverly A
  3. Cancer chemotherapy and pharmacology. 2019, AUG; 84(2): 359-371.
  1. 2.   Ion quantification in liposomal drug products using high performance liquid chromatography
  2. Wu, Jiewei; Crist,Rachael; McNeil,Scott; Clogston,Jeffrey
  3. Journal of pharmaceutical and biomedical analysis. 2019, Feb 20; 165: 41-46.
  1. 3.   Metallic radionuclides in the development of diagnostic and therapeutic radiopharmaceuticals
  2. Bhattacharyya, S.; Dixit, M.
  3. Dalton Transactions. 2011, Jun 21; 40(23): 6112-6128.
  1. 4.   Elevated Phosphate Activates N-ras and Promotes Cell Transformation and Skin Tumorigenesis
  2. Camalier, C. E.; Young, M. R.; Bobe, G.; Perella, C. M.; Colburn, N. H.; Beck, G. R.
  3. Cancer Prevention Research. 2010, Mar; 3(3): 359-370.
  1. 5.   Identification of a Potential Pharmacological Sanctuary for HIV Type 1 in a Fraction of CD4(+) Primary Cells
  2. Valentin, A.; Morrow, M.; Poirier, R. H.; Aleman, K.; Little, R.; Yarchoan, R.; Pavlakis, G. N.
  3. Aids Research and Human Retroviruses. 2010, Jan; 26(1): 79-88.
  1. 6.   Rotational order-disorder structure of fluorescent protein FP480
  2. Pletnev, S.; Morozova, K. S.; Verkhusha, V. V.; Dauter, Z.
  3. Acta crystallographica. Section D, Biological crystallography. 2009, Sep; 65(Pt 9): 906-12.
  1. 7.   IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding
  2. Cer, R. Z.; Mudunuri, U.; Stephens, R.; Lebeda, F. J.
  3. Nucleic Acids Research. 2009 37(Web Server issue): W441-W445.
  1. 8.   Reproducibility of Fifteen Urinary Estrogens and Estrogen Metabolites over a 2-to 3-Year Period in Premenopausal Women
  2. Eliassen, A. H.; Ziegler, R. G.; Rosner, B.; Veenstra, T. D.; Roman, J. M.; Xu, X.; Hankinson, S. E.
  3. Cancer Epidemiology Biomarkers & Prevention. 2009 18(11): 2860-2868.
  1. 9.   C/EBP beta regulates body composition, energy balance-related hormones and tumor growth
  2. Staiger, J.; Lueben, M. J.; Berrigan, D.; Malik, R.; Perkins, S. N.; Hursting, S. D.; Johnson, P. F.
  3. Carcinogenesis. 2009 30(5): 832-840.
  1. 10.   Dynamics of antibody domains studied by solution NMR
  2. Vu, B. K.; Walsh, J. D.; Dimitrov, D. S.; Ishima, R.
  3. Methods in molecular biology (Clifton, N.J.). 2009 525: 533-43, xv.
  1. 11.   Three single-nucleotide polymorphisms in LPA account for most of the increase in lipoprotein(a) level elevation in African Americans compared with European Americans
  2. Chretien, J. P.; Coresh, J.; Berthier-Schaad, Y.; Kao, W. H. L.; Fink, N. E.; Klag, M. J.; Marcovina, S. M.; Giaculli, F.; Smith, M. W.
  3. Journal of Medical Genetics. 2006, Dec; 43(12): 917-923.
  1. 12.   Effects of select PM-associated metals on alveolar macrophage phosphorylated ERK1 and-2 and iNOS expression during ongoing alteration in iron homeostasis
  2. Prophete, C.; Maciejczyk, P.; Salnikow, K.; Gould, T.; Larson, T.; Koenig, J.; Jaques, P.; Sioutas, C.; Lippmann, M.; Cohen, M.
  3. Journal of Toxicology & Environmental Health-Part A-Current Issues. 2006, MAY 15; 69(10): 935-951.
  1. 13.   The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication
  2. Yant, L. J.; Friedrich, T. C.; Johnson, R. C.; May, G. E.; Maness, N. J.; Enz, A. M.; Lifson, J. D.; O'Connor, D. H.; Carrington, M.; Watkins, D. I.
  3. Journal of Virology. 2006, MAY; 80(10): 5074-5077.
  1. 14.   Recombinant production of anti-HIV protein, griffithsin, by auto-induction in a fermentor culture
  2. Giomarelli, B.; Schumacher, K. M.; Taylor, T. E.; Sowder, R. C.; Hartley, J. L.; McMahon, J. B.; Mori, T.
  3. Protein Expression and Purification. 2006, MAY; 47(1): 194-202.
  1. 15.   Development of a quantitative cell-based ELISA, for a humanized anti-IL-2/IL-15 receptor beta antibody (HuMik beta(1)), and correlation with functional activity using an antigen-transfected murine cell line
  2. Yang, X. Y.; Chen, E.; Jiang, H. G.; Hartmann, W. K.; Mitra, G.; Hecht, T.; Soman, G.
  3. Journal of Immunological Methods. 2006, APR 20; 311(1-2): 71-80.
  1. 16.   CB694, a novel antimitotic with antitumor activities
  2. Weiderhold, K. N.; Randall-Hiubek, D. A.; Polin, L. A.; Hamel, E.; Mooberry, S. L
  3. International Journal of Cancer. 2006, FEB 15; 118(4): 1032-1040.
  1. 17.   New arylthioindoles: Potent inhibitors of tubulin polymerization. 2. Structure-activity relationships and molecular modeling studies
  2. De Martino, G.; Edler, M. C.; La Regina, G.; Coluccia, A.; Barbera, M. C.; Barrow, D.; Nicholson, R. I.; Chiosis, G.; Brancale, A.; Hamel, E.; Artico, M.; Silvestri, R.
  3. Journal of Medicinal Chemistry. 2006, FEB 9; 49(3): 947-954.
  1. 18.   Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies
  2. Zhu, Z. Y.; Dimitrov, A. S.; Bossart, K. N.; Crameri, G.; Bishop, K. A.; Choudhry, V.; Mungall, B. A.; Feng, Y. R.; Choudhary, A.; Zhang, M. Y.; Feng, Y.; Wang, L. F.; Xiao, X. D.; Eaton, B. T.; Broder, C. C.; Dimitrov, D. S.
  3. Journal of Virology. 2006, JAN; 80(2): 891-899.
  1. 19.   Chemical library screen for novel inhibitors of Kaposi's sarcoma-associated herpesvirus processive DNA synthesis
  2. Dorjsuren, D.; Burnette, A.; Gray, G. N.; Chen, X. L.; Zhu, W. M.; Roberts, P. E.; Currens, M. J.; Shoemaker, R. H.; Ricciardi, R. P.; Sei, S.
  3. Antiviral Research. 2006, JAN; 69(1): 9-23.
  1. 20.   Novel human monoclonal antibodies to insulin-like growth factor (IGH)-II that potently inhibit the IGF receptor type I signal transduction function
  2. Feng, Y.; Zhu, Z. Y.; Xiao, X. D.; Choudhry, V.; Barrett, J. C.; Dimitrov, D. S.
  3. Molecular Cancer Therapeutics. 2006, JAN; 5(1): 114-120.
  1. 21.   Prednisolone pharmacokinetics in the presence and absence of Ritonavir after oral prednisone administration to healthy volunteers
  2. Penzak, S. R.; Fomnentini, E.; Alfaro, R. M.; Long, M.; Natarajan, V.; Kovacs, J.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2005, DEC 15; 40(5): 573-580.
  1. 22.   Potent antiviral activity of North-methanocarbathymidine against Kaposi's sarcoma-associated herpesvirus
  2. Zhu, W. M.; Burnette, A.; Dorjsuren, D.; Roberts, P. E.; Huleihel, M.; Shoemaker, R. H.; Marquez, V. E.; Agbaria, R.; Sei, S.
  3. Antimicrobial Agents and Chemotherapy. 2005, DEC; 49(12): 4965-4973.
  1. 23.   A transcription inhibitor, Actinomycin D, enhances HIV-1 replication through an interleukin-6-dependent pathway
  2. Imamichi, T.; Conrads, T. P.; Zhou, M.; Liu, Y. X.; Adelsberger, J. W.; Veenstra, T. D.; Lane, H. C.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2005, DEC 1; 40(4): 388-397.
  1. 24.   Absolute oxygen tension (pO(2)) muscle tissue as determined by in murine fatty and EPR
  2. Matsumoto, A.; Matsumoto, S.; Sowers, A. L.; Koscielniak, J. W.; Trigg, N. J.; Kuppusamy, P.; Mitchell, J. B.; Subramanian, S.; Krishna, M. C.; Matsumoto, K.
  3. Magnetic Resonance in Medicine. 2005, DEC; 54(6): 1530-1535.
  1. 25.   Species-specific effects of the hepatocarcinogens 3 '-methyl-4-dimethyl-aminoazobenzene and ortho-aminoazotoluene in mouse and rat liver
  2. Merkulova, T. I.; Kropachev, K. Y.; Timofeeva, O. A.; Vasiliev, G. V.; Levashova, Z. B.; Ilnitskaya, S. I.; Kobzev, V. F.; Pakharukova, M. Y.; Bryzgalov, L. O.; Kaledin, V. I.
  3. Molecular Carcinogenesis. 2005, DEC; 44(4): 223-232.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel